GJOMARKAJ, MARK

GJOMARKAJ, MARK  

FARMACOLOGIA TRASLAZIONALE - IFT  

Mostra records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.012 secondi).
Titolo Data di pubblicazione Autore(i) File
Anti-inflammatory effects of Omalizumab in severe asthmatics. 1-gen-2011 Pace, E; Ferraro, M; Bruno, A; Bousquet, J; Gjomarkaj, Mark
Biologia e Fisiopatologia delle cellule del polmone. 1-gen-2006 GJOMARKAJ M; PACE E; VIGNOLA A.M.
Patologia della pleura 1-gen-2006 Gjomarkaj M; Bonsignore MR.
Effects of low-dose interferon administration on natural killer activity in non-small cell lung cancer during chemotherapy. 1-gen-1989 Bonsignore, G; Spatafora, M; Merendino, A; Chiappara, G; Ferrara, G; Gjomarkaj, Mark; Melis, M; Scotto, Fs; Bellia, V
Immunoperoxidase staining for carcinoembryonic antigen in lung cancer specimens. Lack of correlation with serum levels of the marker at time of diagnosis and during follow-up 1-gen-1989 SPATAFORA M.; MERENDINO A.; GJOMARKAJ M.; GENOVA G.; BELLIA V.; BONSIGNORE G
Modulation of cell mediated immune response by recombinant alpha 2A interferon in non-small cell lung cancer: preliminary results. 1-gen-1988 . SPATAFORA M.; . MERENDINO A.M.; . GJOMARKAJ M.; . CHIAPPARA G.; SPINNATO C.; FERRARO G.; SCOTTO FS.; .FERRARA G.; . BELLIA V.